Publications by authors named "Barbara Radecka"

Claim this Profile
R
Real-world treatment patterns of hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer.
Barbara Radecka, Bogdan Żurawski, Aleksandra Łacko, Aleksandra Anna Grela-Wojewoda, Karolina Wieruszewska-Kowalczyk

Contemp Oncol (Pozn)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study.
Renata Duchnowska, Katarzyna Soter, Katarzyna Pogoda, Jolanta Smok-Kalwat, Aleksandra Grela-Wojewoda, Barbara Radecka

Breast· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Antifolate Chemotherapy Does Not Select for Fluconazole-Resistant : A Multicenter Clinical Study.
Dawid Żyrek, Joanna Nowicka, Magdalena Pajączkowska, Mariola Paściak, Katarzyna Machnik, Barbara Radecka

Pathogens· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of patients with BRAF-mutated metastatic colorectal cancer: a Polish retrospective cohort study.
Jolanta Żok, Michał Bieńkowski, Barbara Radecka, Agata Kuchar, Szymon Borowiec

Contemp Oncol (Pozn)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil.
Mateusz Malik, Barbara Radecka, Marek Gełej, Aleksandra Jackowska, Emilia Filipczyk-Cisarż

Biomedicines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High tumour-infiltrating lymphocytes correlate with distinct gene expression profile and favourable survival in single hormone receptor-positive breast cancer.
Aleksandra Ciarka, Michał Kunc, Marta Popęda, Aleksandra Łacko, Barbara Radecka

Contemp Oncol (Pozn)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma - a prospective single-arm study.
Michał Piątek, Michał Bieńkowski, Katarzyna Kuśnierz, Joanna Pilch-Kowalczyk, Dorota Imielska-Zdunek, Barbara Radecka

Contemp Oncol (Pozn)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/valsartan for cardioprotection in breast cancer (MAINSTREAM): design and rationale of the randomized trial.
Mateusz Tajstra, Maciej Dyrbuś, Tomasz Rutkowski, Krzysztof Składowski, Barbara Sosnowska-Pasiarska, Barbara Radecka

ESC Heart Fail· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-9 expression on tumour-associated immune cells is associated with favourable clinicopathological features and better outcomes in oral squamous cell carcinoma.
Rafał Pęksa, Michał Kunc, Michał Piątek, Barbara S Radecka, Barbara Alicja Jereczek-Fossa

Contemp Oncol (Pozn)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Budding Is an Independent Prognostic Factor in Pancreatic Adenocarcinoma and It Positively Correlates with PD-L1 Expression on Tumor Cells.
Rafał Pęksa, Michał Kunc, Piotr Czapiewski, Michał Piątek, Stanisław Hać, Barbara Radecka

Biomedicines· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.
Michał Kunc, Rafał Pęksa, Gabor Cserni, Ewa Iżycka-Świeszewska, Aleksandra Łacko, Barbara Radecka

Pathology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Usefulness of Prognostic Tools in Breast Cancer Patients with Brain Metastases.
Joanna Kufel-Grabowska, Anna Niwińska, Barbara S Radecka, Shan Ali, Tomasz Mandat

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil.
Mateusz Malik, Maciej Michalak, Barbara Radecka, Marek Gełej, Aleksandra Jackowska

J Clin Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.
Jolanta Żok, Michał Bieńkowski, Barbara Radecka, Jan Korniluk, Krzysztof Adamowicz

BMC Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of heat shock proteins in neoplastic processes and the research on their importance in the diagnosis and treatment of cancer.
Iryna Boliukh, Agnieszka Rombel-Bryzek, Olga Żuk, Barbara Radecka

Contemp Oncol (Pozn)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early palliative care of non-small cell lung cancer in the context of immunotherapy.
Małgorzata Pieniążek, Piotr Pawlak, Barbara Radecka

Oncol Lett· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
Michał Kunc, Marta Popęda, Magdalena Niemira, Anna Szałkowska, Michał Bieńkowski, Barbara S Radecka

Diagnostics (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.
Beata Hryciuk, Rafał Pęksa, Michał Bieńkowski, Bartosz Szymanowski, Barbara Radecka

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Natalie C Wu, Wendy Wong, Kenneth E Ho, Victor C Chu, Annaliza Rizo, Barbara Radecka

Breast Cancer Res Treat· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer in young women.
Barbara Radecka, Maria Litwiniuk

Ginekol Pol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review.
Marlena Janiczek, Łukasz Szylberg, Anna Kasperska, Adam Kowalewski, Martyna Parol, Barbara Radecka

J Immunol Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab.
Renata Duchnowska, Jeff Sperinde, Bogumiła Czartoryska-Arłukowicz, Paulina Myśliwiec, John Winslow, Barbara Radecka

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
Renata Duchnowska, Michał Jarząb, Jadwiga Żebracka-Gala, Rafał Matkowski, Anna Kowalczyk, Barbara Radecka

Clin Breast Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis.
Renata Duchnowska, Rafał Pęksa, Barbara Radecka, Tomasz Mandat, Tomasz Trojanowski

Breast Cancer Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients.
Renata Duchnowska, Piotr J Wysocki, Konstanty Korski, Bogumiła Czartoryska-Arłukowicz, Anna Niwińska, Barbara Radecka

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis